Brookline, MA, United States of America

Shourya Sonkar Roy Burman

This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shourya Sonkar Roy Burman. Retrieved from https://idiyas.com/inventor/shourya-sonkar-roy-burman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shourya Sonkar Roy Burman: Innovator in Protein Modulation

Introduction

Shourya Sonkar Roy Burman is an accomplished inventor based in Brookline, MA (US). He has made significant contributions to the field of protein modulation, particularly through his innovative patent.

Latest Patents

Shourya holds a patent for a "Protein tag to induce ligand dependent degradation of protein/protein-fusions." This patent describes compositions and methods for modulating protein abundance in a target-specific manner via degron tags. His work in this area is crucial for advancing our understanding of protein dynamics and their implications in various biological processes.

Career Highlights

Shourya is currently associated with the Dana-Farber Cancer Institute Inc., where he applies his expertise in protein research. His role at this prestigious institution allows him to contribute to groundbreaking research in cancer treatment and therapy.

Collaborations

Shourya has collaborated with notable colleagues, including Eric S. Fischer and Tyler Faust. These collaborations enhance the research environment and foster innovation in their respective fields.

Conclusion

Shourya Sonkar Roy Burman is a prominent figure in the realm of protein research, with a focus on innovative solutions for protein modulation. His contributions are paving the way for advancements in cancer research and treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…